OncoSynergy has joined forces with the Musella Foundation For Brain Tumor Research & Information, Inc
100% of donation made on the page virtualtrials.com/oncosynergy will go to fund this trial. We need to raise $60,000 to get the first patient treated then work on raising more to help get the entire trial completed. We can speed this up by funding it now.
Posted on: 07/29/2020
has joined forces with the
to raise funds for the company's FDA approved Phase 1 clinical trial in recurrent glioblastoma.
OncoSynergy is a biotechnology company developing innovative therapeutics to improve outcomes for patients suffering from the worst cancers. Glioblastoma has always been at the heart of the company's mission as OncoSynergy was founded by neurosurgeons and scientists frustrated with the lack of effective treatment options and the inability to cure glioblastoma with a scalpel.
OncoSynergy is ready to bring its innovative solution to patients. Our goal is to raise at least $60,000 to fund treatment of at least 1 patient in our FDA approved trial. With your support, we hope to exceed this goal and be able to treat more glioblastoma patients. Each patient we treat helps us and the oncology community better understand how our therapeutic, OS2966, works against cancer. This is powerful information that will allow us to address the shortcomings of today's approach to cancer and translate this cancer treatment to the entire oncology population.OncoSynergy has joined forces with the Musella Foundation For Brain Tumor Research & Information, Inc
Click HERE to return to brain tumor news headlines